JCI insight

JCI Insight is a Gold Open Access journal with a 2022 Impact Factor of 8.0. It publishes high-quality studies in various biomedical specialties, such as autoimmunity, gastroenterology, immunology, metabolism, nephrology, neuroscience, oncology, pulmonology, and vascular biology. The journal focuses on clinically relevant basic and translational research that contributes to the understanding of disease biology and treatment. JCI Insight is self-published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists founded in 1908, and it helps fulfill the ASCI's mission to advance medical science through the publication of clinically relevant research reports.

JCI Insight 是一本开放获取的高水平期刊，其2022年的影响因子达到了8.0。该期刊发表各种生物医学专业的优质研究，涵盖自身免疫、胃肠病学、免疫学、新陈代谢、肾病学、神经科学、肿瘤学、肺病学和血管生物学等领域。期刊专注于临床相关的基础和转化研究，有助于深入理解疾病的生物学机制以及治疗方法。JCI Insight 由美国临床研究学会（ASCI）自行出版，ASCI是一个成立于1908年的非营利性荣誉组织，旨在通过发表临床相关研究报告来推动医学科学的进步。